BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35922192)

  • 1. [Efficacy and safety of modified hemophagocytic lymphohistiocytosis 04 regimen in Beijing Children's Hospital].
    Cheng FF; Ma HH; Jiao Y; Wei A; Lian HY; Wang D; Yang Y; Zhao XX; Li ZG; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):804-809. PubMed ID: 35922192
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of pediatric primary hemophagocytic lymphohistiocytosis with the HLH-94/2004 regimens and hematopoietic stem cell transplantation in China.
    Ma H; Zhang R; Zhang L; Wei A; Zhao X; Yang Y; Liu W; Li Z; Qin M; Wang T
    Ann Hematol; 2020 Oct; 99(10):2255-2263. PubMed ID: 32766934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study on the effect of etoposide-containing induction regimen for adult-onset Still's disease associated hemophagocytic syndrome].
    He LB; Jin ZL; Liu MH; Wu L; Wang Z; Wang YN
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(29):2322-2327. PubMed ID: 34333949
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ruxolitinib combined with liposomal doxorubicin, etoposide, methylprednisolone+/-PEG-asparaginase in treatment of relapsed/refractory pediatric hemophagocytic lymphohistiocytosis].
    Wei A; Ma HH; Zhang LP; Lian HY; Du JY; Wang D; Cui L; Ou WX; Zhao YZ; Zhao XX; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Yi Xue Za Zhi; 2022 Jul; 102(28):2167-2172. PubMed ID: 35872580
    [No Abstract]   [Full Text] [Related]  

  • 5. Profile of hemophagocytic lymphohistiocytosis; efficacy of intravenous immunoglobulin therapy.
    Rajajee S; Ashok I; Manwani N; Rajkumar J; Gowrishankar K; Subbiah E
    Indian J Pediatr; 2014 Dec; 81(12):1337-41. PubMed ID: 24806152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between genotype and clinical phenotype in children with primary hemophagocytic lymphohistiocytosis].
    Zhang LP; Ma HH; Wei A; Zhang R; Li ZG; Wang TY
    Zhonghua Er Ke Za Zhi; 2021 Aug; 59(8):672-677. PubMed ID: 34333920
    [No Abstract]   [Full Text] [Related]  

  • 7. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
    J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children.
    Wei A; Ma H; Li Z; Zhang L; Zhang Q; Wang D; Lian H; Zhang R; Wang T
    Int J Hematol; 2020 Oct; 112(4):568-576. PubMed ID: 32666469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe neurologic side effects in patients being treated for hemophagocytic lymphohistiocytosis.
    Thompson PA; Allen CE; Horton T; Jones JY; Vinks AA; McClain KL
    Pediatr Blood Cancer; 2009 May; 52(5):621-5. PubMed ID: 19137570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified DEP regimen as induction therapy for lymphoma-associated hemophagocytic lymphohistiocytosis: a prospective, multicenter study.
    Pi Y; Wang J; Zhou H; Ye X; Sun X; Liu L; Pan X; Wang Z
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3033-3041. PubMed ID: 35852619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children].
    Zhao YZ; Ma HH; Lian HY; Wang D; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2024 May; 62(5):467-472. PubMed ID: 38623016
    [No Abstract]   [Full Text] [Related]  

  • 12. L-DEP regimen salvage therapy for paediatric patients with refractory Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis.
    Zhao Y; Li Z; Zhang L; Lian H; Ma H; Wang D; Zhao X; Zhang Q; Wang T; Zhang R
    Br J Haematol; 2020 Nov; 191(3):453-459. PubMed ID: 32525580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of 9 cases of drug induced hypersensitivity syndrome related hemophagocytic lymphohistiocytosis].
    Zhao YZ; Ma HH; Wang D; Lian HY; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):60-65. PubMed ID: 38154979
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent.
    Rajagopala S; Singh N
    Acta Med Acad; 2012; 41(2):161-74. PubMed ID: 23331391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
    Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and molecular characteristics of
    Li RB; He XH; Fang BL; Yang Y; Yao KH; Qian SY
    Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):209-214. PubMed ID: 35240740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of five cases of hepatitis associated aplastic anemia presenting with hemophagocytic lymphohistiocytosis at onset].
    Wei A; Ma HH; Zhang LP; Wu RH; Zhang R; Wang TY
    Zhonghua Er Ke Za Zhi; 2020 Mar; 58(3):213-217. PubMed ID: 32135593
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophagocytic Lymphohistiocytosis Associated with Histiocytic Necrotizing Lymphadenitis: A Clinical Study of 13 Children and Literature Review.
    Yang Y; Lian H; Ma H; Zhao Y; Zhang Q; Zhang L; Wang T; Li Z; Zhang R
    J Pediatr; 2021 Feb; 229():267-274.e3. PubMed ID: 32956695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study of DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis].
    Wang Y; Huang W; Wei N; Zeng X; Zhang J; Wang J; Wu L; Fu L; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):901-4. PubMed ID: 25339326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.